A Feasibility Study on Deep Learning-Based Radiotherapy Dose Calculation by Xing, Yixun et al.
 
 
 1 
Technical Note: A Feasibility Study on Deep Learning-Based 
Radiotherapy Dose Calculation 
Yixun Xing, Dan Nguyen, Weiguo Lu, Ming Yang, Steve Jiang† 
Medical Artificial Intelligence and Automation (MAIA) Laboratory, Department of Radiation 
Oncology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA 
†Correspondence author. Email: Steve.Jiang@UTSouthwestern.edu 
Abstract 
Purpose: Various dose calculation algorithms are available for radiation therapy for 
cancer patients. However, these algorithms are faced with the tradeoff between 
efficiency and accuracy. The fast algorithms are generally less accurate, while the 
accurate dose engines are often time consuming. In this work, we try to resolve this 
dilemma by exploring deep learning (DL) for dose calculation.  
Methods: We developed a new radiotherapy dose calculation engine based on a 
modified Hierarchically Densely Connected U-net (HD U-net) model and tested its 
feasibility with prostate intensity-modulated radiation therapy (IMRT) cases. Mapping 
from an IMRT fluence map domain to a 3D dose domain requires a deep neural 
network of complicated architecture and a huge training dataset. To solve this 
problem, we first project the fluence maps to the dose domain using a modified ray-
tracing algorithm, and then we use the HD U-net to map the ray-tracing dose 
distribution into an accurate dose distribution calculated using a collapsed cone 
convolution/superposition (CS) algorithm.  
Results: It takes about one second to compute a 3D dose distribution for a typical 7-
field prostate IMRT plan, which can be further reduced to achieve real-time dose 
calculation by optimizing the network. For all eight testing patients, evaluation with 
Gamma Index and various clinical goals for IMRT optimization shows that the DL 
dose distributions are clinically identical to the CS dose distributions.  
Conclusions: We have shown the feasibility of using DL for calculating radiotherapy 
dose distribution with high accuracy and efficiency.  
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1. Introduction 
Various dose calculation algorithms have been developed for cancer 
radiotherapy and are available in commercial treatment planning systems (TPSs), 
ranging from simple pencil beam models to more complicated 
convolution/superposition algorithms to even more advanced Monte Carlo methods. 
It is well known that simple dose engines like pencil beam models can be fast but 
less accurate, while advanced algorithms like Monte Carlo methods can be very 
accurate but slow. Ahnesjo et al. provided a comprehensive review of various dose 
calculation algorithms used for external beam photon radiation therapy.1 Overall, 
there is a tradeoff between calculation efficiency and accuracy for all dose 
calculation algorithms. There is a clinical need to develop new dose engines that are 
both accurate and efficient.  
Recently, deep learning (DL) has become a driver of many new real-world 
applications ranging from language translation2,3 to computer vision.4,5 A deep 
learning architecture, U-net,6 has been successfully applied to predict dose 
distributions for prostate cancer radiotherapy.7 The model was also modified to 
predict the dose distributions for head and neck cancer patients and lung cancer 
patients with heterogeneous beam setups.7-9  
In this work, we explore the feasibility of using DL for accurate and fast 
radiotherapy dose calculation. Specifically, we test the Hierarchically Densely 
connected U-net (HD U-net) model for intensity-modulated radiation therapy (IMRT) 
dose calculation for prostate cancer patients using a low-accuracy, first-order prior 
as input.  
 
2. Methods and Materials 
 
2.1. Deep neural network architecture 
Because of domain differences, directly mapping from 2D fluence maps to a 3D 
dose distribution could be challenging for DL, requiring a complicated network 
structure and a large amount of training data. Projecting the fluence maps first into 
the dose domain to use as a prior would greatly simplify the model itself and its 
training. Our idea is to use ray-tracing (RT) dose calculation,10 which is fast and 
inexpensive, to obtain a prior from the fluence maps and the patient CT as input for 
the DL model. In this feasibility study, we use the dose distributions from the 
collapsed cone convolution/superposition (CS algorithm11-13 as the desired output 
dose distribution. The RT algorithm provides inaccurate dose calculation because it 
does not consider the scatter components from the primary beam. The CS algorithm 
is considered accurate in this regard and has been widely used in clinical practice. 
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Thus, the dose calculation problem can be translated into a mapping problem from 
the RT dose distribution to the CS dose distribution using DL, and we designed a 
deep neural network to learn the relationship between the RT and the CS dose 
distributions and to capture the scattering effect. Keep in mind that the DL model can 
be trained with the output data from any accurate dose calculation algorithm. 
 
Figure 1. Schematic of the HD U-net architecture used for the dose calculation. The number above 
the boxes represents the number of concatenated features, and those to the left show the size of the 
three-dimensional feature maps.9  
Figure 1 shows the neural network architecture, HD U-net, used in this work. The 
general HD U-net structure was proposed for three-dimensional dose prediction for 
head and neck cancer patients.9 We adopted the main neural network operations of 
the original HD U-net and made modifications to the architecture. As can be seen in 
Figure 1, the HD U-net contains five levels to reduce the feature size from 
128×128×16 down to 8×8×1, where 2×2×2 max pooling was performed between 
layers. The convolutional kernel of size 3×3×3 was implemented during convolution 
with zero padding to maintain the feature size. Sixteen feature maps were used in 
each convolutional step on the left half of the network. On the right half of the 
network, the number of filters increased by 16 for each level from the bottom to the 
top. The convolution and rectified linear unit (ReLU) operations were followed by 
batch normalization (BN) in the HD U-net, as suggested for dose prediction with U-
net.7 Because we observed no overfitting issue, we kept the dropout rate at 0. The 
learning rate was carefully adjusted to 10-4, and the Adam algorithm14 was selected 
as the optimizer to minimize the loss function of the mean squared error (MSE). The 
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deep learning model was built and implemented in Keras with Tensorflow15 as the 
back end. 
2.2. Data collection 
We used 78 prostate IMRT patients in this feasibility study. For each patient, the 
treatment plan with seven 6-MV photon beams was re-calculated using both RT and 
CS algorithms. The input and output volume dimensions were 256×256×64 for 77 
patients and 256×256×62 for the remaining one patient.  
2.3. Training and evaluation 
Seventy patients were randomly assigned as the training data, and the remaining 
eight patients were held aside as separate testing data. A five-fold cross-validation 
was performed during the training stage to assess the performance stability and 
variability of the proposed HD U-net model. The 70 patients were divided into 5 folds 
with 14 patients in each fold. For every training round, four folds (56 patients) were 
used for training, and the last fold was reserved for validation. The weights were 
randomly initialized for each round and then updated based on its training dataset. 
The five-fold training results were collected and assessed to ensure stability before a 
final model was constructed on the 70 patients combined. The final model was then 
tested on the other eight patients.  
During each training iteration, a patch of size 128×128×16 was randomly 
selected from the patient CT and dose images. This training-by-patch method, 
similar to data augmentation, could reduce overfitting. The number of epochs, with 
around 56 iterations in each epoch, was optimized through fine tuning and 
determined to be 300. 
For the eight testing cases, we computed the gamma passing rate at 1mm/1% 
and 2mm/2% for the assessment. We also analyzed the statistics, including the 
mean, standard deviation, minimum, and maximum of the differences between CS 
and DL dose distributions for various IMRT clinical goals. We also calculated the 
dose volume histogram (DVH) comparison of CS, RT, and DL dose distributions for 
testing patients.  In addition, we computed the error histograms for critical regions. 
The DL model was trained on NVIDIA Tesla K80 dual-GPU cards with 12 GB 
dedicated RAM. The evaluation on testing patients was performed on one NVIDIA 
Tesla V100 GPU card with 32 GB dedicated RAM. 
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3. Results 
 
 
 
Figure 2. The average loss across the 5 cross-validation folds, where the solid line represents the training 
loss and the dashed line shows the validation loss. 
 
 
 
Figure 2 displays the training and validation losses for the HD U-net. Generally, 
both the training and validation losses decrease as the epoch increases. Based on 
all five validation losses, we observed no over-fitting issue.  
The trained model was applied to calculate the eight testing plans, and the 
average calculation time was 1.19 seconds with a standard deviation of 0.01 
seconds. Figure 3 illustrates the CS dose (a), the DL dose (b) and their difference (c) 
distributions loaded on the CT slice for an example patient. As can be seen, the DL 
dose is very close to the CS dose, with a difference of less than ~2% of the 
prescription dose. Figure 3 (d) shows the DVH curves for the same patient. The solid 
lines represent the CS dose, while the dashed lines and the dotted lines represent 
the DL and RT doses, respectively. One can see that the DL DVH curves are 
completely covered by the CS DVH curves and can hardly be seen in Figure 3 (d), 
indicating a clinically acceptable accuracy for the DL dose and a considerable 
improvement from the RT dose. 
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Figure 3. (a) One slice of the CS dose distribution; (b) the corresponding slice of the DL dose 
distribution; (c) the relative dose difference (஽ವಽି஽಴ೄ
஽ೃೣ
 ) distribution; and (d) the DVH plots of the CS 
(solid), the DL (dashed), and the RT (dotted) doses for one example patient. 
Table 1 shows the gamma passing rates at 1mm/1% and 2mm/2% criteria for the 
DL doses for the eight testing patients, using the CS dose as the reference. As can 
be seen, the gamma analysis indicates the high accuracy of the DL dose in both 
settings. The gamma passing rate for the 1mm/1% criterion is as high as 98.50% on 
average with a standard deviation of 1.6%. For the 2mm/2% criterion, the 
corresponding numbers become 99.9% and 0.10%. These numbers indicate that 
there is essentially no clinically meaningful difference between DL and CS dose 
distributions. Table 2 displays the mean, standard deviation, min, and max of the 
difference in IMRT optimization objectives between CS and DL dose calculations. 
The differences of DL and CS algorithms in the D95 of PTV for the eight testing 
patients fall between -1.38 Gy and 0.66 Gy where the average difference is -0.25 
Gy. For the percent volume difference at various dose levels for rectum (75 Gy, 70 
Gy, 65 Gy, 45 Gy), bladder (80 Gy, 75 Gy, 70 Gy, 65 Gy), and femoral heads (50 
Gy), the mean values are within ±0.16%, the standard deviations are less than 
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0.35%, the minimum values are greater than -0.97%, and the maximum values are 
less than 0.4%. The difference in mean dose for femoral heads is also negligibly 
small. All of these numbers indicate that the two dose distributions computed by DL 
and CS are clinically identical. 
Table 1. The Gamma passing rate for DL dose calculation of the eight testing patients.  
 Gamma Index 
Criterion 1mm/1% 2mm/2% 
Patient 
1 99.10% 100% 
2 99.90% 100% 
3 97.60% 100% 
4 99.80% 100% 
5 99.90% 100% 
6 99.90% 100% 
7 95.70% 99.70% 
8 96.30% 99.80% 
Mean 98.50% 99.90% 
SD 1.60% 0.10% 
 
Table 2. The mean, standard deviation, min, and max of the difference (DL-CS) in IMRT objectives 
between DL and CS dose calculations for the eight testing patients. The volume differences are in 
percent volume and the dose differences are in Gy. 
  Mean SD Min Max 
PTV D95 -0.25 0.67 -1.38 0.66 
Rectum 
V75 -0.16% 0.32% -0.78% 0.27% 
V70 -0.16% 0.35% -0.97% 0.10% 
V65 -0.09% 0.20% -0.46% 0.14% 
V45 -0.13% 0.13% -0.33% 0.08% 
Bladder 
V80 0.02% 0.26% -0.44% 0.40% 
V75 0.04% 0.10% -0.12% 0.18% 
V70 0.04% 0.12% -0.08% 0.21% 
V65 0.01% 0.12% -0.16% 0.16% 
Femoral 
Heads 
Dmean -0.02 0.13 -0.24 0.12 
V50 0.00% 0.00% 0.00% 0.00% 
 
4. Conclusions 
To our knowledge, this is the first instance of successful dose calculation for 
radiotherapy using deep learning. It is well known that there is a tradeoff between 
efficiency and accuracy for all existing dose calculation engines. Our work shows 
that deep learning-based methods may be able to achieve a high dose calculation 
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accuracy with a high efficiency, which may play an important role for real-time 
adaptive radiation therapy. Also, since the deep learning-based methods are 
completely different from the existing measurement-based or model-based methods, 
they can also be used for secondary dose verification.  
5. Acknowledgements 
We would like to thank the Cancer Prevention and Research Institute of Texas 
(CPRIT) for providing support through grants IIRACA RP160190 and IIRA 
RP150485. 
  
 
 
 9 
References 
1. Ahnesjo A, Aspradakis MM. Dose calculations for external photon beams in radiotherapy. Phys 
Med Biol. 1999;44(11):R99-R155. 
2. Luong M-T, Pham H, Manning CD. Effective approaches to attention-based neural machine 
translation. arXiv preprint. 2015;arXiv:1508.04025. 
3. Lee J, Cho K, Hofmann T. Fully character-level neural machine translation without explicit 
segmentation. arXiv preprint. 2017;arXiv:1610.03017. 
4. Simonyan K, Zisserman A. Very deep convolutional networks for large-scale image recognition. 
arXiv preprint. 2014;arXiv:1409.1556. 
5. He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. arXiv preprint. 
2015;arXiv:1512.03385. 
6. Ronneberger O, Fischer P, Brox T. U-Net: convolutional networks for biomedical image 
segmentation. Medical Image Computing and Computer-Assisted Intervention – MICCAI 2015 
Lecture Notes in Computer Science. 2015;9351:234-241. 
7. Nguyen D, Long T, Jia X, et al. Dose prediction with U-net: a feasibility study for predicting dose 
distributions from contours using deep learning on prostate IMRT patients. arXiv preprint. 
2017;arXiv:1709.09233. Scientific Reports. 2019;9(1):1076. 
8. Barragan-Montero AM, Nguyen D, Lu W, et al. Three-dimensional dose prediction for lung IMRT 
patients with deep neural networks: robust learning from heterogeneous beam configurations. 
arXiv preprint. 2018;arXiv:1812.06934. 
9. Nguyen D, Jia X, Sher D, et al. 3D radiotherapy dose prediction on head and neck cancer patients 
with a hierarchically densely connected U-net deep learning architecture. arXiv preprint. 2018; 
arXiv:1805.10397. Phys Med Biol. 2019;64(6). 
10. Lu W, Chen M. Fluence-convolution broad-beam (FCBB) dose calculation. Phys Med Biol. 
2010;55(23):7211-7229. 
11. Ahnesjo A. Collapsed cone Convolution of radiant energy for photon dose calculation in 
heterogeneous media. Med Phys. 1989;16(4):577-592. 
12. Ulmer W, Kaissl W. The inverse problem of a Gaussian convolution and its application to the 
finite size of the measurement chambers/detectors in photon and proton dosimetry. Phys Med 
Biol. 2003;48(6):707-727. 
13. Ulmer W, Pyyry J, Kaissl W. A 3D photon superposition/convolution algorithm and its foundation 
on results of Monte Carlo calculations. Phys Med Biol. 2005;50(8):1767-1790. 
14. Kingma DP, Ba J. Adam: A method for stochastic optimization. arXiv preprint. 
2014;arXiv:1412.6980. 
15. Abadi M, Agarwal A, Barham P, et al. Tensorflow: Large-scale machine learning on 
heterogeneous distributed systems. arXiv preprint. 2016; arXiv:1603.04467. 
 
